Literature DB >> 27037575

C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress.

Niran Maharjan1,2, Christina Künzli1, Kilian Buthey1, Smita Saxena3.   

Abstract

Hexanucleotide repeat expansions in the C9ORF72 gene are causally associated with frontotemporal lobar dementia (FTLD) and/or amyotrophic lateral sclerosis (ALS). The physiological function of the normal C9ORF72 protein remains unclear. In this study, we characterized the subcellular localization of C9ORF72 to processing bodies (P-bodies) and its recruitment to stress granules (SGs) upon stress-related stimuli. Gain of function and loss of function experiments revealed that the long isoform of C9ORF72 protein regulates SG assembly. CRISPR/Cas9-mediated knockdown of C9ORF72 completely abolished SG formation, negatively impacted the expression of SG-associated proteins such as TIA-1 and HuR, and accelerated cell death. Loss of C9ORF72 expression further compromised cellular recovery responses after the removal of stress. Additionally, mimicking the pathogenic condition via the expression of hexanucleotide expansion upstream of C9ORF72 impaired the expression of the C9ORF72 protein, caused an abnormal accumulation of RNA foci, and led to the spontaneous formation of SGs. Our study identifies a novel function for normal C9ORF72 in SG assembly and sheds light into how the mutant expansions might impair SG formation and cellular-stress-related adaptive responses.

Entities:  

Keywords:  ALS; C9ORF72; Cell recovery; Motor neuron degeneration; Stress granules

Mesh:

Substances:

Year:  2016        PMID: 27037575     DOI: 10.1007/s12035-016-9850-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

1.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

2.  SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress.

Authors:  Tie Zou; Xianming Yang; Danmin Pan; Jia Huang; Mustafa Sahin; Jianhua Zhou
Journal:  Cell Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.046

3.  The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules.

Authors:  A Wilczynska; C Aigueperse; M Kress; F Dautry; D Weil
Journal:  J Cell Sci       Date:  2005-03-01       Impact factor: 5.285

4.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Catherine Lomen-Hoerth; Thomas Anderson; Bruce Miller
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

5.  Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells.

Authors:  Ilmin Kwon; Siheng Xiang; Masato Kato; Leeju Wu; Pano Theodoropoulos; Tao Wang; Jiwoong Kim; Jonghyun Yun; Yang Xie; Steven L McKnight
Journal:  Science       Date:  2014-07-31       Impact factor: 47.728

6.  Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules.

Authors:  Ute Nonhoff; Markus Ralser; Franziska Welzel; Ilaria Piccini; Daniela Balzereit; Marie-Laure Yaspo; Hans Lehrach; Sylvia Krobitsch
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

7.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05

8.  The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.

Authors:  Kohji Mori; Shih-Ming Weng; Thomas Arzberger; Stephanie May; Kristin Rentzsch; Elisabeth Kremmer; Bettina Schmid; Hans A Kretzschmar; Marc Cruts; Christine Van Broeckhoven; Christian Haass; Dieter Edbauer
Journal:  Science       Date:  2013-02-07       Impact factor: 47.728

9.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

10.  Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly.

Authors:  S J Seguin; F F Morelli; J Vinet; D Amore; S De Biasi; A Poletti; D C Rubinsztein; S Carra
Journal:  Cell Death Differ       Date:  2014-07-18       Impact factor: 15.828

View more
  40 in total

1.  C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.

Authors:  Christopher P Cali; Maribel Patino; Yee Kit Tai; Wan Yun Ho; Catriona A McLean; Christopher M Morris; William W Seeley; Bruce L Miller; Carles Gaig; Jean Paul G Vonsattel; Charles L White; Sigrun Roeber; Hans Kretzschmar; Juan C Troncoso; Claire Troakes; Marla Gearing; Bernardino Ghetti; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Kin Y Mok; Helen Ling; Dennis W Dickson; Gerard D Schellenberg; Shuo-Chien Ling; Edward B Lee
Journal:  Acta Neuropathol       Date:  2019-07-20       Impact factor: 17.088

2.  Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72.

Authors:  Noori Chai; Michael S Haney; Julien Couthouis; David W Morgens; Alyssa Benjamin; Kathryn Wu; James Ousey; Shirleen Fang; Sarah Finer; Michael C Bassik; Aaron D Gitler
Journal:  Brain Res       Date:  2019-12-13       Impact factor: 3.252

3.  High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype.

Authors:  Orly Goldstein; Mali Gana-Weisz; Beatrice Nefussy; Batel Vainer; Omri Nayshool; Anat Bar-Shira; Bryan J Traynor; Vivian E Drory; Avi Orr-Urtreger
Journal:  Neurobiol Aging       Date:  2017-12-27       Impact factor: 4.673

4.  Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis.

Authors:  Nikolas Santamaria; Marwa Alhothali; Maria Harreguy Alfonso; Leonid Breydo; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2016-11-12       Impact factor: 9.261

Review 5.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

Review 6.  Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.

Authors:  Xinmei Wen; Thomas Westergard; Piera Pasinelli; Davide Trotti
Journal:  Neurosci Lett       Date:  2016-09-13       Impact factor: 3.046

Review 7.  Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.

Authors:  Jie Jiang; John Ravits
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 8.  C9orf72-mediated ALS and FTD: multiple pathways to disease.

Authors:  Rubika Balendra; Adrian M Isaacs
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

9.  C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly.

Authors:  Tao Wang; Honghe Liu; Kie Itoh; Sungtaek Oh; Liang Zhao; Daisuke Murata; Hiromi Sesaki; Thomas Hartung; Chan Hyun Na; Jiou Wang
Journal:  Cell Metab       Date:  2021-02-04       Impact factor: 27.287

Review 10.  Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.

Authors:  Weilun Pang; Fenghua Hu
Journal:  J Neurochem       Date:  2020-12-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.